High depression symptomatology and mental pain characterize suicidal psychiatric patients.

Depression symptomatology hopelessness mental pain psychopharmacological medications suicide behaviors and ideation

Journal

European psychiatry : the journal of the Association of European Psychiatrists
ISSN: 1778-3585
Titre abrégé: Eur Psychiatry
Pays: England
ID NLM: 9111820

Informations de publication

Date de publication:
31 08 2022
Historique:
pubmed: 31 8 2022
medline: 20 9 2022
entrez: 30 8 2022
Statut: epublish

Résumé

Symptoms of depression are transdiagnostic heterogenous features frequently assessed in psychiatric disorders, that impact the response to first-line treatment and are associated with higher suicide risk. This study assessed whether severe mental pain could characterize a specific phenotype of severely depressed high-risk psychiatric patients. We also aimed to analyze differences in treatments administered. 2,297 adult patients (1,404 females and 893 males; mean age = 43.25 years, SD = 15.15) treated in several Italian psychiatric departments. Patients were assessed for psychiatric diagnoses, mental pain, symptoms of depression, hopelessness, and suicide risk. More than 23% of the patients reported high depression symptomatology and high mental pain (HI DEP/HI PAIN). Compared to patients with lower symptoms of depression, HI DEP/HI PAIN is more frequent among females admitted to an inpatient department and is associated with higher hopelessness and suicide risk. In addition, HI DEP/HI PAIN (compared to both patients with lower symptoms of depression and patients with higher symptoms of depression but lower mental pain) were more frequently diagnosed in patients with personality disorders and had different treatments. Patients reporting severe symptoms of depression and high mental pain presented a mixture of particular dangerousness (high trait hopelessness and the presence of suicide ideation with more frequency and less controllability and previous suicide behaviors). The presence of severe mental pain may act synergically in expressing a clinical phenotype that is likewise treated with a more complex therapeutic regime than that administered to those experiencing symptoms of depression without mental pain.

Sections du résumé

BACKGROUND
Symptoms of depression are transdiagnostic heterogenous features frequently assessed in psychiatric disorders, that impact the response to first-line treatment and are associated with higher suicide risk. This study assessed whether severe mental pain could characterize a specific phenotype of severely depressed high-risk psychiatric patients. We also aimed to analyze differences in treatments administered.
METHODS
2,297 adult patients (1,404 females and 893 males; mean age = 43.25 years, SD = 15.15) treated in several Italian psychiatric departments. Patients were assessed for psychiatric diagnoses, mental pain, symptoms of depression, hopelessness, and suicide risk.
RESULTS
More than 23% of the patients reported high depression symptomatology and high mental pain (HI DEP/HI PAIN). Compared to patients with lower symptoms of depression, HI DEP/HI PAIN is more frequent among females admitted to an inpatient department and is associated with higher hopelessness and suicide risk. In addition, HI DEP/HI PAIN (compared to both patients with lower symptoms of depression and patients with higher symptoms of depression but lower mental pain) were more frequently diagnosed in patients with personality disorders and had different treatments.
CONCLUSIONS
Patients reporting severe symptoms of depression and high mental pain presented a mixture of particular dangerousness (high trait hopelessness and the presence of suicide ideation with more frequency and less controllability and previous suicide behaviors). The presence of severe mental pain may act synergically in expressing a clinical phenotype that is likewise treated with a more complex therapeutic regime than that administered to those experiencing symptoms of depression without mental pain.

Identifiants

pubmed: 36041998
doi: 10.1192/j.eurpsy.2022.2312
pii: S0924933822023124
pmc: PMC9491079
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e54

Références

J Psychiatr Res. 2015 Feb;61:1-12
pubmed: 25586212
Harv Rev Psychiatry. 2019 Jul/Aug;27(4):209-216
pubmed: 31274577
World Psychiatry. 2020 Feb;19(1):51-52
pubmed: 31922691
World Psychiatry. 2021 Oct;20(3):387-396
pubmed: 34505365
World Psychiatry. 2020 Oct;19(3):266-268
pubmed: 32931119
Suicide Life Threat Behav. 2008 Feb;38(1):116-21
pubmed: 18355113
Am J Psychiatry. 1990 Feb;147(2):190-5
pubmed: 2278535
Ann Gen Psychiatry. 2020 Oct 12;19:61
pubmed: 33062034
Aust N Z J Psychiatry. 2011 Aug;45(8):619-28
pubmed: 21740345
Brain Behav Immun Health. 2021 Jul 28;16:100303
pubmed: 34589795
Int J Environ Res Public Health. 2020 Apr 01;17(7):
pubmed: 32244611
Front Psychiatry. 2020 Dec 21;11:591460
pubmed: 33408654
World Psychiatry. 2021 Oct;20(3):444-445
pubmed: 34505363
Front Psychiatry. 2016 Jun 20;7:108
pubmed: 27378956
World Psychiatry. 2020 Feb;19(1):108-109
pubmed: 31922681
J Nerv Ment Dis. 1993 Mar;181(3):145-7
pubmed: 8445372
Psychother Psychosom. 2019;88(6):341-349
pubmed: 31665739
J Consult Clin Psychol. 1974 Dec;42(6):861-5
pubmed: 4436473
Am J Psychiatry. 2011 Dec;168(12):1266-77
pubmed: 22193671
J Affect Disord. 2013 Sep 5;150(2):216-22
pubmed: 23684516
Eur Psychiatry. 2020 Sep 07;63(1):e85
pubmed: 32892754
Schizophr Bull. 2017 Mar 1;43(2):240-244
pubmed: 27421793
World Psychiatry. 2020 Oct;19(3):269-293
pubmed: 32931110
Ann Gen Psychiatry. 2019 May 31;18:7
pubmed: 31164909
J Clin Psychiatry. 2018 May/Jun;79(3):
pubmed: 28872267
World Psychiatry. 2020 Feb;19(1):40-50
pubmed: 31922678
Suicide Life Threat Behav. 2007 Jun;37(3):264-77
pubmed: 17579539
World Psychiatry. 2020 Jun;19(2):214-232
pubmed: 32394557
J Consult Clin Psychol. 1989 Apr;57(2):309-10
pubmed: 2708621
Neuropsychiatr Dis Treat. 2019 Aug 07;15:2257-2271
pubmed: 31496708
Ann N Y Acad Sci. 1986;487:90-6
pubmed: 3471167
Psychiatry Res. 2010 Feb 28;181(2):141-4
pubmed: 20074915
Suicide Life Threat Behav. 2003 Fall;33(3):219-30
pubmed: 14582833
Nord J Psychiatry. 2017 Jan;71(1):72-76
pubmed: 27626513
J Clin Psychiatry. 2015 Dec;76(12):1683-6
pubmed: 26717528
Am J Psychiatry. 1985 May;142(5):559-63
pubmed: 3985195
J Affect Disord. 2010 Jan;120(1-3):226-30
pubmed: 19394086
World Psychiatry. 2021 Jun;20(2):283-293
pubmed: 34002502
Psychiatry Res. 2017 Mar;249:23-29
pubmed: 28063394
Suicide Life Threat Behav. 2007 Jun;37(3):248-63
pubmed: 17579538
Psychiatry. 2018 Fall;81(3):240-257
pubmed: 30183526
World Psychiatry. 2021 Oct;20(3):439-441
pubmed: 34505359
Suicide Life Threat Behav. 2014 Feb;44(1):78-88
pubmed: 24106764
J Clin Psychiatry. 2022 Jun 15;83(4):
pubmed: 35704708
BMC Psychiatry. 2021 May 17;21(1):257
pubmed: 34001045
World Psychiatry. 2020 Feb;19(1):1-2
pubmed: 31922672

Auteurs

Maurizio Pompili (M)

Department of Neurosciences, Mental Health, and Sensory Organs, Faculty of Medicine and Psychology, Suicide Prevention Centre, Sant'Andrea Hospital, Sapienza University of Rome, Rome, Italy.

Marco Innamorati (M)

Department of Human Sciences, European University of Rome, Rome, Italy.

Denise Erbuto (D)

Department of Neurosciences, Mental Health, and Sensory Organs, Faculty of Medicine and Psychology, Suicide Prevention Centre, Sant'Andrea Hospital, Sapienza University of Rome, Rome, Italy.

Mario Luciano (M)

Department of Psychiatry, University of Campania "L. Vanvitelli", Naples, Italy.

Gaia Sampogna (G)

Department of Psychiatry, University of Campania "L. Vanvitelli", Naples, Italy.

Giovanni Abbate-Daga (G)

Eating Disorders Center, Department of Neuroscience, University of Turin, Turin, Italy.

Stefano Barlati (S)

Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy.
Department of Mental Health and Addiction Services, ASST Spedali Civili of Brescia, Brescia, Italy.

Claudia Carmassi (C)

Psychiatric Clinic, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.

Giovanni Castellini (G)

Psychiatry Unit, Department of Health Sciences, University of Florence, Florence, Italy.

Pasquale De Fazio (P)

Psychiatric Unit, Department of Health Sciences, University Magna Graecia, Catanzaro, Italy.

Giorgio Di Lorenzo (G)

Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy.

Marco Di Nicola (M)

Department of Neuroscience, Section of Psychiatry, Università Cattolica del Sacro Cuore, Rome, Italy.
Department of Psychiatry, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy.

Silvia Ferrari (S)

Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Modena, Italy.
Dipartimento ad Attività Integrata di Salute Mentale e Dipendenze Patologiche, AUSL - IRCCS Reggio Emilia, Reggio Emilia, Italy.

Arianna Goracci (A)

Department of Molecular Medicine, University of Siena, Siena, Italy.

Carla Gramaglia (C)

Department of Translational Medicine, Università del Piemonte Orientale, Novara, Italy.
Psychiatry Division, Azienda Ospedaliero Universitaria Maggiore della Carità, Novara, Italy.

Giovanni Martinotti (G)

Department of Neuroscience, Imaging and Clinical Sciences, University "G. D'Annunzio" of Chieti-Pescara, Chieti, Italy.

Maria Giulia Nanni (MG)

Department of Neuroscience and Rehabilitation, Institute of Psychiatry, University of Ferrara, Ferrara, Italy.

Massimo Pasquini (M)

Department of Human Neurosciences, Sapienza University of Rome, Rome, Italy.

Federica Pinna (F)

Section of Psychiatry, Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy.

Nicola Poloni (N)

Division of Psychiatry, Department of Medicine and Surgery, University of Insubria, Varese, Italy.

Gianluca Serafini (G)

Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, and Maternal and Child Health, Psychiatry Section, University of Genoa, IRCCS San Martino, Genoa, Italy.

Maria Signorelli (M)

Department of Clinical and Experimental Medicine, AOU Policlinico Hospital, University of Catania, Catania, Italy.

Alfonso Tortorella (A)

Department of Psychiatry, University of Perugia, Perugia, Italy.

Antonio Ventriglio (A)

Department of Clinical and Experimental Medicine, University of Foggia, Foggia, Italy.

Umberto Volpe (U)

Unit of Clinical Psychiatry, Department of Neurosciences/DIMSC, School of Medicine and Surgery, Polytechnic University of Marche, Ancona, Italy.

Andrea Fiorillo (A)

Department of Psychiatry, University of Campania "L. Vanvitelli", Naples, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH